Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4871137
Max Phase: Preclinical
Molecular Formula: C46H65N9O7S
Molecular Weight: 888.15
Molecule Type: Unknown
Associated Items:
ID: ALA4871137
Max Phase: Preclinical
Molecular Formula: C46H65N9O7S
Molecular Weight: 888.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(Oc1cccc(N2CCC[C@@H](C(=O)N(CCOCCOCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)Cc3ccc(-c4cn[nH]c4)cc3)C2)c1)C(=O)N1CCNCC1
Standard InChI: InChI=1S/C46H65N9O7S/c1-46(2,44(58)53-20-16-47-17-21-53)62-38-9-5-8-37(27-38)54-19-6-7-35(31-54)43(57)55(30-33-12-14-34(15-13-33)36-28-49-50-29-36)22-24-61-26-25-60-23-18-48-41(56)11-4-3-10-40-42-39(32-63-40)51-45(59)52-42/h5,8-9,12-15,27-29,35,39-40,42,47H,3-4,6-7,10-11,16-26,30-32H2,1-2H3,(H,48,56)(H,49,50)(H2,51,52,59)/t35-,39+,40+,42+/m1/s1
Standard InChI Key: FQXPPXPFMPQLGV-RHPBCFIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 888.15 | Molecular Weight (Monoisotopic): 887.4728 | AlogP: 3.79 | #Rotatable Bonds: 22 |
Polar Surface Area: 182.49 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.46 | CX Basic pKa: 7.82 | CX LogP: 2.52 | CX LogD: 1.96 |
Aromatic Rings: 3 | Heavy Atoms: 63 | QED Weighted: 0.07 | Np Likeness Score: -1.38 |
1. Wang Z, Zhang M, Quereda V, Frydman SM, Ming Q, Luca VC, Duckett DR, Ji H.. (2021) Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction., 64 (16.0): [PMID:34382808] [10.1021/acs.jmedchem.1c00742] |
Source(1):